|
DDX3X expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5550999999947E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.27739999986754E-07 |
| Normal-vs-Stage2 |
1.782040E-02 |
| Normal-vs-Stage3 |
1.468270E-02 |
| Normal-vs-Stage4 |
3.371200E-04 |
| Stage1-vs-Stage2 |
5.542600E-01 |
| Stage1-vs-Stage3 |
3.753800E-01 |
| Stage1-vs-Stage4 |
6.174600E-01 |
| Stage2-vs-Stage3 |
8.837600E-01 |
| Stage2-vs-Stage4 |
4.048000E-01 |
| Stage3-vs-Stage4 |
3.433600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66180000052918E-07 |
| Normal-vs-AfricanAmerican |
3.618400E-04 |
| Normal-vs-Asian |
4.996400E-02 |
| Caucasian-vs-AfricanAmerican |
4.030800E-01 |
| Caucasian-vs-Asian |
7.518800E-01 |
| AfricanAmerican-vs-Asian |
9.823000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19349974347926E-10 |
| Normal-vs-Female |
7.465600E-01 |
| Male-vs-Female |
7.87380000089044E-08 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.103330E-03 |
| Normal-vs-Extreme_Weight |
2.43450000048107E-07 |
| Normal-vs-Obese |
5.017400E-04 |
| Normal-vs-Extreme_Obese |
1.154630E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.084350E-01 |
| Normal_Weight-vs-Obese |
8.227000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.137400E-01 |
| Extreme_Weight-vs-Obese |
3.647900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.427800E-01 |
| Obese-vs-Extreme_Obese |
2.217800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.532160E-01 |
| Normal-vs-Age(41-60Yrs) |
2.586700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.10349999973936E-07 |
| Normal-vs-Age(81-100Yrs) |
9.56389999999807E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.722800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.252400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.855600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.488190E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.125400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.572600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.72989999997131E-06 |
| Normal-VS-Type2 PRCC |
2.31459999999739E-06 |
| Normal-VS-KIRP CIMP |
4.688000E-01 |
| Normal-VS-Unclassified PRCC |
3.104600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.128000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.056230E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.650600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.171180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.955600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.500800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.27189999935496E-08 |
| Normal-vs-N1 |
9.177800E-02 |
| Normal-vs-N2 |
2.351600E-02 |
| N0-vs-N1 |
4.200300E-02 |
| N0-vs-N2 |
8.016800E-01 |
| N1-vs-N2 |
4.649000E-01 |
|
|
